Abstract
Introduction

Allogeneic bone marrow transplantation (BMT) remains an important treatment for young patients with severe aplastic anemia who have an HLA-compatible sibling donor.
Most centers now report long-term survival rates of 60% to 100% (1, 2) (Fig. 2) (7, (9) (10) (11) 
Results of Chimerism Studies
Bone marrow and blood chimerism was repeatedly evaluated by a quantitative method that uses fluorescence-based polymerase chain reaction amplification of short tandem repeat markers (4). The proportion of recipient-type cells in
. Although we did not evaluate chimerism of non-T cells including granulocytes posttransplantation for this patient, the proportion of recipient-type cells of total peripheral blood was consistently low compared to that of peripheral T cells, which accounted for 20-30% of total peripheral blood. The proportion of recipient-type cells of non-T cells is considered lower than that of T cells.
F i g u r e 2 . T h e p r o p o r t i o n o f r e c i p i e n t -t y p e c e l l s i n t h e t o t a l p e r i p h e r a l b l o o d ( T o t a l P B ) , p e r i p he r a l b l o o d T c e l l s ( P B T ) a n d b o n e ma r r o w ( B M) . F l u o r e s c e n c e -b a s e d p o l y me r a s e c h a i n r e a c t i o n a mp l i f i c a t i o n o f s h o r t t a n d e m r e p e a t ma r k e r s wa s u s e d .
Discussion
Stable mixed chimerism has been commonly described in canine models for non-myeloablative transplantation (5, 6). In a vast majority of clinical settings of non-myeloablative transplantation in humans, however, mixed chimerism appears to represent a temporary status prior to full donor chimerism or rejection of donor cells (7). Mixed chimerism has also been demonstrated posttransplant in patients with aplastic anemia, but it reportedly precedes donor cell rejection and bone marrow failure (8). Prolongation or appearance of posttransplant mixed chimerism is often related to T-cell depletion, transplantation for aplastic anemia, younger recipient ages, complete matching of HLAs, and non-TBI conditioning regimens in the literature
